BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/08/2014

FDA Clears JADELLE Implant for Approval

The FDA has determined that the 75mg JADELLE levonorgestrel implant was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →